¼¼°èÀÇ ¸ð¹ÙÀÏ ÀÇ·á ¾Û ½ÃÀå
Mobile Medical Apps
»óǰÄÚµå : 1770182
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 573 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,222,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,666,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¸ð¹ÙÀÏ ÀÇ·á ¾Û ¼¼°è ½ÃÀåÀº 2030³â±îÁö 425¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 104¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¸ð¹ÙÀÏ ÀÇ·á ¾Û ¼¼°è ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö CAGR 26.5%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 425¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ÀÇ·á ¸ð´ÏÅ͸µÀº CAGR 25.7%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 102¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿µ¾ç¡¤ÇÇÆ®´Ï½º ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 29.6%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº ÃßÁ¤ 36¾ï ´Þ·¯, Áß±¹Àº CAGR 31.4%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ¸ð¹ÙÀÏ ÀÇ·á ¾Û ½ÃÀåÀº 2024³â¿¡ 36¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGR 31.4%¸¦ ±â·ÏÇϸç 2030³â±îÁö 47¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, ºÐ¼® ±â°£ µ¿¾È CAGRÀº °¢°¢ 21.2%¿Í 25.3%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR ¾à 24.2%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ¸ð¹ÙÀÏ ÀÇ·á ¾Û ½ÃÀå µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

¸ð¹ÙÀÏ ÀÇ·á ¾ÛÀº ȯÀÚ¿Í ÀÇ·áÁø¿¡°Ô ÀÇ·á Á¤º¸¿Í ¼­ºñ½º¿¡ ´ëÇÑ Æí¸®ÇÑ ½Ç½Ã°£ ¾×¼¼½º¸¦ Á¦°øÇÔÀ¸·Î½á ÇコÄÉ¾î »ê¾÷¿¡ Çõ¸íÀ» ÀÏÀ¸Ä×½À´Ï´Ù. ÀÌ·¯ÇÑ ¾ÛÀº ¸¸¼ºÁúȯ °ü¸®, º¹¾à ¾Ë¸², ¿ø°ÝÀÇ·á »ó´ã, ÇÇÆ®´Ï½º Æ®·¡Å· µî ´Ù¾çÇÑ ±â´ÉÀ» Æ÷ÇÔÇϰí ÀÖ½À´Ï´Ù. ¸ð¹ÙÀÏ ÀÇ·á ¾ÛÀ» ÅëÇØ ȯÀÚ´Â ÀÇ·á±â°üÀ» ¹æ¹®ÇÏÁö ¾Ê°íµµ ÀÚ½ÅÀÇ °Ç°­ »óŸ¦ Áö¼ÓÀûÀ¸·Î ¸ð´ÏÅ͸µÇϰí, Áõ»óÀ» ÃßÀûÇϰí, ÀÇ·á Àü¹®°¡¿Í ¼ÒÅëÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù¼º°ú ÆíÀǼºÀº Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µ°ú Àû½Ã °³ÀÔÀÌ Áß¿äÇÑ ´ç´¢º´, °íÇ÷¾Ð, ½ÉÀ庴°ú °°Àº ¸¸¼ºÁúȯÀÇ °ü¸®¿¡ ƯÈ÷ À¯¿ëÇÕ´Ï´Ù. ¶ÇÇÑ, ƯÁ¤ °Ç°­ »óÅ¿¡ ¸Â°Ô ¼³°èµÈ ¾ÛÀº °³ÀÎÈ­µÈ Á¶¾ð°ú Áö¿øÀ» Á¦°øÇÏ¿© ȯÀÚÀÇ Ä¡·á °èȹ ÁؼöÀ²°ú Àü¹ÝÀûÀÎ °Ç°­ °á°ú¸¦ Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù.

ÀΰøÁö´É(AI), ¸Ó½Å·¯´×(ML), °í±Þ µ¥ÀÌÅÍ ºÐ¼® µî ¸ð¹ÙÀÏ ÀÇ·á ¾ÛÀ» Áö¿øÇÏ´Â ±â¼úÀº ºü¸£°Ô ¹ßÀüÇϰí ÀÖÀ¸¸ç, AI ±â¹Ý Áø´Ü µµ±¸´Â Áõ»ó°ú º´·ÂÀ» ºÐ¼®ÇÏ¿© Áø´Ü °¡´É¼ºÀ» Á¦¾ÈÇϰí Ãß°¡ Á¶Ä¡¸¦ ±ÇÀåÇÒ ¼ö ÀÖ½À´Ï´Ù. ÃßõÇÒ ¼ö ÀÖ½À´Ï´Ù. ¸Ó½Å·¯´× ¾Ë°í¸®ÁòÀº °³ÀÎÀÇ °Ç°­ µ¥ÀÌÅÍ¿Í Çൿ¿¡ µû¶ó ±ÇÀå »çÇ×À» Á¶Á¤ÇÏ¿© »ç¿ëÀÚ °æÇèÀ» °³ÀÎÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¿þ¾î·¯ºí ±â±â¿Í ¸ð¹ÙÀÏ ¾ÛÀÇ ÅëÇÕÀ¸·Î ±â´ÉÀÌ °­È­µÇ¾î ½É¹Ú¼ö, Ç÷´ç, ½Åü Ȱµ¿·®°ú °°Àº »ýü µ¥ÀÌÅ͸¦ ½Ç½Ã°£À¸·Î ¼öÁýÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ÀÌ µ¥ÀÌÅ͸¦ ¸ð¹ÙÀÏ ¾Û°ú ¿øÈ°ÇÏ°Ô µ¿±âÈ­ÇÏ¿© »ç¿ëÀÚÀÇ °Ç°­ »óŸ¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, º¸´Ù Á¤È®ÇÑ ¸ð´ÏÅ͸µ°ú °ü¸®°¡ ¿ëÀÌÇØÁý´Ï´Ù. ¹Î°¨ÇÑ °Ç°­ µ¥ÀÌÅÍÀÇ ¾ÈÀüÇÑ ÀúÀå ¹× Àü¼ÛÀº °­·ÂÇÑ ¾Ïȣȭ¿Í HIPAA(Health Insurance Interoperability and Accountability Act)¿Í °°Àº ÇコÄÉ¾î ±ÔÁ¤ Áؼö¸¦ ÅëÇØ º¸ÀåµË´Ï´Ù.

¸ð¹ÙÀÏ ÀÇ·á ¾Û ½ÃÀåÀÇ ¼ºÀåÀº ¸î °¡Áö ¿äÀο¡ ÀÇÇØ ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. ÷´Ü ¼¾¼­ÀÇ °³¹ß°ú ½º¸¶Æ®ÆùÀÇ ±â´É Çâ»ó°ú °°Àº ±â¼ú ¹ßÀüÀ¸·Î ¸ð¹ÙÀÏ ÀÇ·á ¾ÛÀÇ ±â´É°ú Á¤È®µµ°¡ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ±âÁ¸ ÀÇ·á ȯ°æ ¹Û¿¡¼­ °Ç°­ »óŸ¦ °ü¸®ÇÒ ¼ö ÀÖ´Â Æí¸®Çϰí È¿°úÀûÀÎ ¹æ¹ýÀ» Á¦°øÇϱ⠶§¹®¿¡ ÀÌ·¯ÇÑ ¾ÛÀÇ Ã¤ÅÃÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, COVID-19 »çÅ´ ¿ø°ÝÀÇ·á ¹× µðÁöÅÐ Çコ ¼Ö·ç¼ÇÀ¸·ÎÀÇ ÀüȯÀ» °¡¼ÓÈ­Çϰí, À§±â »óȲ¿¡¼­ ÀÇ·á ¼­ºñ½ºÀÇ ¿¬¼Ó¼ºÀ» À¯ÁöÇÏ´Â µ¥ ÀÖ¾î ¸ð¹ÙÀÏ ÀÇ·á ¾ÛÀÇ Á߿伺À» °­Á¶Çϰí ÀÖ½À´Ï´Ù. ½º¸¶Æ®Æù°ú ¸ð¹ÙÀÏ ÀÎÅͳÝÀÇ º¸±Þ°ú ÇÔ²² µðÁöÅÐ Çコ Åø¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ Àνİú ¼ö¿ëµµ°¡ ³ô¾ÆÁø °Íµµ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, µðÁöÅÐ Çコ ±â¼ú Ȱ¿ëÀ» ÃËÁøÇÏ´Â Á¤ºÎ Áö¿øÃ¥°ú ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©°¡ ¸ð¹ÙÀÏ ÀÇ·á ¾ÛÀÇ Ã¤ÅÃÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀÌ Á¾ÇÕÀûÀ¸·Î ¸ð¹ÙÀÏ ÀÇ·á ¾Û ½ÃÀåÀÇ ¼ºÀåÀ» °ßÀÎÇϰí ÀÖÀ¸¸ç, ¸ð¹ÙÀÏ ÀÇ·á ¾ÛÀº Çö´ë ÀÇ·á ¼­ºñ½º Á¦°ø¿¡ ÇʼöÀûÀÎ ¿ä¼Ò·Î ÀÚ¸® Àâ°í ÀÖ½À´Ï´Ù.

ºÎ¹®

¼­ºñ½º(ÀÇ·á ¸ð´ÏÅ͸µ, ¿µ¾ç°ú ÇÇÆ®´Ï½º, ÀÇ·á ÂüÁ¶, Áø´Ü, Ä¡·á, ±âŸ ¼­ºñ½º), ÃÖÁ¾ ¿ëµµ(ȯÀÚ, ÀÇ·á Á¦°øÀÚ), ¿ëµµ(´ç´¢º´, ½ÉÇ÷°ü, È£Èí±â, ±âŸ ¿ëµµ)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê

AI ÅëÇÕ

Global Industry Analysts´Â °ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI ÅøÀ» ÅëÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ Çõ½ÅÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM ¹× ¾÷°è °íÀ¯ÀÇ SLMÀ» Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹üÀ» µû¸£´Â ´ë½Å ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¸ÅÃâ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Mobile Medical Apps Market to Reach US$42.5 Billion by 2030

The global market for Mobile Medical Apps estimated at US$10.4 Billion in the year 2024, is expected to reach US$42.5 Billion by 2030, growing at a CAGR of 26.5% over the analysis period 2024-2030. Medical Monitoring, one of the segments analyzed in the report, is expected to record a 25.7% CAGR and reach US$10.2 Billion by the end of the analysis period. Growth in the Nutrition & Fitness segment is estimated at 29.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.6 Billion While China is Forecast to Grow at 31.4% CAGR

The Mobile Medical Apps market in the U.S. is estimated at US$3.6 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$4.7 Billion by the year 2030 trailing a CAGR of 31.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 21.2% and 25.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 24.2% CAGR.

Global Mobile Medical Apps Market - Key Trends & Drivers Summarized

Mobile medical apps have revolutionized the healthcare industry by providing patients and healthcare providers with convenient, real-time access to medical information and services. These apps encompass a wide range of functionalities, from chronic disease management and medication reminders to telemedicine consultations and fitness tracking. Mobile medical apps enable patients to monitor their health conditions continuously, track symptoms, and communicate with healthcare professionals without needing to visit a medical facility. This ease of access and convenience is particularly beneficial for managing chronic diseases such as diabetes, hypertension, and heart disease, where continuous monitoring and timely interventions are crucial. Additionally, apps designed for specific health conditions can provide personalized advice and support, improving patient adherence to treatment plans and overall health outcomes.

The technology underpinning mobile medical apps has advanced rapidly, incorporating features such as artificial intelligence (AI), machine learning (ML), and advanced data analytics. AI-powered diagnostic tools can analyze symptoms and medical history to suggest potential diagnoses or recommend further action. Machine learning algorithms can personalize user experiences by adapting recommendations based on individual health data and behaviors. Furthermore, the integration of wearable devices with mobile apps has enhanced their functionality, enabling the collection of real-time biometric data such as heart rate, blood glucose levels, and physical activity. This data can be seamlessly synced with mobile apps, providing a comprehensive view of the user's health and facilitating more accurate monitoring and management. The secure storage and transmission of sensitive health data are ensured through robust encryption and compliance with healthcare regulations such as HIPAA (Health Insurance Portability and Accountability Act).

The growth in the mobile medical apps market is driven by several factors. Technological advancements, such as the development of sophisticated sensors and the increasing capabilities of smartphones, have expanded the functionality and accuracy of mobile medical apps. The rising prevalence of chronic diseases and the growing demand for remote patient monitoring solutions have fueled the adoption of these apps, as they offer convenient and effective ways to manage health conditions outside traditional healthcare settings. Additionally, the COVID-19 pandemic has accelerated the shift towards telemedicine and digital health solutions, highlighting the importance of mobile medical apps in maintaining healthcare continuity during crises. The increasing consumer awareness and acceptance of digital health tools, coupled with the widespread penetration of smartphones and mobile internet, have also contributed to market growth. Moreover, supportive government initiatives and regulatory frameworks promoting the use of digital health technologies have further propelled the adoption of mobile medical apps. These factors collectively drive the expansion of the mobile medical apps market, making them an integral part of modern healthcare delivery.

SCOPE OF STUDY:

The report analyzes the Mobile Medical Apps market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Service (Medical Monitoring, Nutrition & Fitness, Medical Reference, Diagnostic, Treatment, Other Services); End-Use (Patients, Healthcare Providers); Application (Diabetes, Cardiovascular, Respiratory, Other Applications)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 92 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â